# A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma

> **NCT06207305** · PHASE1,PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 39 (estimated)

## Conditions studied

- Metastatic Appendiceal Adenocarcinoma
- Intraperitoneal Paclitaxel

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Diphenhydramine
- **DRUG:** Famotidine
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT06207305
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-30
- **Primary completion:** 2028-01-02
- **Final completion:** 2028-01-02
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207305, "A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06207305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*